Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: J Thorac Oncol. 2012 May;7(5):833–840. doi: 10.1097/JTO.0b013e31824de09c

Figure 1.

Figure 1

Photomicrographs showing immunohistochemical expression of FRα, FRC1 and TS in NSCLC tissue specimens by histologic type. FRα: A, strong cytoplasmic and membrane expression in tumor cells; B and C, moderate expression in tumor cells; D, lack of expression in malignant cells. RFC1: E and G, strong cytoplasmic expression in malignant cells. TS: F and H, negative and moderate cytoplasmic and nuclear expression in tumor cells, respectively. Original magnification, ×200.